Original Research Articles
14 October 2025
Vol. 32 No. 2 (2025)
Effects of laser acupuncture (stress-free therapy) on blood liver function indicators
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
0
Views
0
Downloads
Authors
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide. Metabolic disorders, including glucose and lipid disorders, exacerbate liver pathophysiology in patients with MASLD. We have previously demonstrated that laser acupuncture (stress-free therapy; SFT) improves glucose and lipid metabolism. Additionally, we have found that SFT can increase blood flow throughout the body and decrease stress-related hormones. The purpose of this study was to examine whether SFT can improve liver function test values. This investigation was conducted as a retrospective cohort study, including 185 subjects (females/males: 89/96; age: 64.3±11.8 years). Blood samples were collected from all subjects before and after SFT. We measured liver function indicators, glucose levels, and lipid levels, and compared the value of each factor before and after SFT using the Wilcoxon signed-rank test for paired comparisons. Liver function indicators (aspartate aminotransferase [AST], alanine aminotransferase [ALT], lactate dehydrogenase, total bilirubin, and alkaline phosphatase) significantly decreased after SFT. Blood levels of total cholesterol (T-Chol) and glucose also significantly reduced after SFT. The gamma-glutamyl transpeptidase (GGT) level did not change after SFT. Subgroup analysis by gender did not modify the overall findings. Findings from this large-scale study indicate that SFT may significantly improve liver function indicators. These results highlight the potential of SFT as an effective therapeutic strategy for MASLD.
Altmetrics
Downloads
Download data is not yet available.
Citations
1. Ito T, Ishigami M, Zou B, et al. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040. Hepatol Int 2021;15:366-79. DOI: https://doi.org/10.1007/s12072-021-10143-4
2. Jung I, Lee DY, Lee MY, et al. Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease. Front Endocrinol (Lausanne) 2021;12:752944. DOI: https://doi.org/10.3389/fendo.2021.752944
3. Wang J, Cui JJ, Ha LJ, et al. [Review on application of neural tracing technique to experimental research of acupuncture]. Zhen Ci Yan Jiu 2019;44:926-31.
4. Park JY and Namgung U. Electroacupuncture therapy in inflammation regulation: current perspectives. J Inflamm Res 2018;11:227-37. DOI: https://doi.org/10.2147/JIR.S141198
5. Wang LH, Huang W, Wei D, et al. Mechanisms of Acupuncture Therapy for Simple Obesity: An Evidence-Based Review of Clinical and Animal Studies on Simple Obesity. Evid Based Complement Alternat Med 2019;2019:5796381. DOI: https://doi.org/10.1155/2019/5796381
6. Ishimaru K, Nakajima T, Namiki Y, et al. Influences of Pinpoint Plantar Long-Wavelength Infrared Light Irradiation (Stress-Free Therapy) on Chorioretinal Hemodynamics, Atherosclerosis Factors, and Vascular Endothelial Growth Factor. Integr Med Res 2018;7:103-7. DOI: https://doi.org/10.1016/j.imr.2017.12.002
7. Ryotokuji K, Nakajima T, Ishimaru K, et al. Effect of Stress-Free Therapy on immune system: Induction of Interleukin 10 expression in lymphocytes through activation of CD19(+) CD24(hi) CD38(hi) regulatory B Cells. Laser Ther 2015;24:179-88. DOI: https://doi.org/10.5978/islsm.15-OR-11
8. Ryotokuji K, Ishimaru K, Kihara K, et al. Preliminary results of highly localized plantar irradiation with low incident levels of mid-infrared energy which contributes to the prevention of dementia associated with underlying diabetes mellitus. Laser Ther 2015;24:27-32. DOI: https://doi.org/10.5978/islsm.15-OR-03
9. Ryotokuji K, Ishimaru K, Kihara K, et al. Effect of Stress-free Therapy on Cerebral Blood Flow: Comparisons among patients with metabolic cardiovascular disease, healthy subjects and placebo-treated subjects. Laser Ther 2014;23:9-12. DOI: https://doi.org/10.5978/islsm.14-OR-02
10. Ryotokuji K, Ishimaru K, Kihara K, et al. Effect of pinpoint plantar long-wavelength infrared light irradiation on subcutaneous temperature and stress markers. Laser Ther 2013;22:93-102. DOI: https://doi.org/10.5978/islsm.13-OR-08
11. Ryotokuji K, Ishimaru K, Kihara K, et al. Preliminary results of pinpoint plantar long-wavelength infrared light irradiation on blood glucose, insulin and stress hormones in patients with type 2 diabetes mellitus. Laser Ther 2013;22:209-14. DOI: https://doi.org/10.5978/islsm.13-OR-18
12. Gupta A, Keshri GK, Yadav A, et al. Superpulsed (Ga-As, 904 nm) low-level laser therapy (LLLT) attenuates inflammatory response and enhances healing of burn wounds. J Biophotonics 2015;8:489-501. DOI: https://doi.org/10.1002/jbio.201400058
13. Martins Filho HMA, Mangueira M, Nóbrega LGD, et al. Effects of Laser Acupuncture on Metabolic Functions of Sedentary People: A Double-Blind Randomized Clinical Trial. Photobiomodul Photomed Laser Surg 2024;42:716-24. DOI: https://doi.org/10.1089/photob.2023.0162
14. Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 2014;12:1495-9. DOI: https://doi.org/10.1016/j.ijsu.2014.07.013
15. Jenkins PA, Carroll JD. How to report low-level laser therapy (LLLT)/photomedicine dose and beam parameters in clinical and laboratory studies. Photomed Laser Surg 2011;29:785-7. DOI: https://doi.org/10.1089/pho.2011.9895
16. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 2024.
17. Fujii H, Suzuki Y, Sawada K, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: A large-scale multicenter retrospective study. Hepatol Res 2023;53:1059-72. DOI: https://doi.org/10.1111/hepr.13947
18. Iwaki M, Fujii H, Hayashi H, et al. Prognosis of biopsy-confirmed metabolic dysfunction- associated steatotic liver disease: A sub-analysis of the CLIONE study. Clin Mol Hepatol 2024;30:225-34. DOI: https://doi.org/10.3350/cmh.2023.0515
19. Duell PB, Welty FK, Miller M, et al. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol 2022;42:e168-85. DOI: https://doi.org/10.1161/ATV.0000000000000153
20. ElSayed NA, Aleppo G, Aroda VR, et al. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46:S49-67. DOI: https://doi.org/10.2337/dc23-S004
21. Russell G, Lightman S. The human stress response. Nat Rev Endocrinol 2019;15:525-34. DOI: https://doi.org/10.1038/s41574-019-0228-0
22. He Y, Gao H, Li X, et al. Psychological stress exerts effects on pathogenesis of hepatitis B via type-1/type-2 cytokines shift toward type-2 cytokine response. PLoS One 2014;9:e105530. DOI: https://doi.org/10.1371/journal.pone.0105530
23. Ye J, Yu Y, Chung RCK, et al. The relationship between liver function and neurophysiological factors in depressed individuals: a cross-sectional study using an integrated "East meets West" medicine approach. Front Psychiatry 2023;14:1159785. DOI: https://doi.org/10.3389/fpsyt.2023.1159785
24. Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 2015;149:389-97.e10. DOI: https://doi.org/10.1053/j.gastro.2015.04.043
25. Fujii H, Iwaki M, Hayashi H, et al. Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study. Clin Gastroenterol Hepatol 2023;21:370-9. DOI: https://doi.org/10.1016/j.cgh.2022.01.002
26. Castera L, Laouenan C, Vallet-Pichard A, et al. High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold. Diabetes Care 2023;46:1354-62. DOI: https://doi.org/10.2337/dc22-2048
27. Jang H, Kim Y, Lee DH, et al. Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver Disease. JAMA Intern Med 2024. DOI: https://doi.org/10.1001/jamainternmed.2023.8029
28. Sofias AM, De Lorenzi F, Peña Q, et al. Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. Adv Drug Deliv Rev 2021;175:113831. DOI: https://doi.org/10.1016/j.addr.2021.113831
29. Hung CH, Lee CM, Wang JH, et al. Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy. Int J Cancer 2011;128:2344-52. DOI: https://doi.org/10.1002/ijc.25585
How to Cite
Effects of laser acupuncture (stress-free therapy) on blood liver function indicators. (2025). Laser Therapy, 32(2). https://doi.org/10.4081/ltj.2025.403
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
